埃博拉疫苗气雾剂成功通过动物实验_时事

埃博拉疫苗气雾剂成功通过动物实验

A single dose of a new Ebola vaccine that can beinhaled has been found to neutralize the deadlyvirus in monkeys, researchers reported on Monday.

研究人员周一通报称，已发现一种新的可吸入型埃博拉疫苗，只需一剂便可抵御猴子体内的致命性病毒。

The study, published in the Journal of Clinical Investigation, demonstrated that the aerosolEbola vaccine activated immune cells in the respiratory system of rhesus macaques andprovided full protection against the virus. The study was conducted by researchers at TheUniversity of Texas Medical Branch in Galveston and the National Institutes of Health inBethesda, Md. It was the first attempt to use an aerosol to vaccinate monkeys against ahemorrhagic viral fever, the study’s authors said.

发表在《临床调查杂志》(Journal of Clinical Investigation)上的该论文证明，该气雾型埃博拉疫苗激活了恒河猴呼吸系统内的免疫细胞，提供了针对该疫苗的完全防护。进行研究的是德克萨斯大学加尔维斯顿医学分部(University of Texas Medical Branch in Galveston)和位于马里兰州贝塞斯达的美国国家卫生研究院(National Institutes of Health)的研究人员。文章作者称，这是首次尝试用气雾剂给猴子接种防治病毒性出血热的疫苗。

“The initial several decades of attempts to develop a vaccine against the Ebola virus wereunsuccessful, said Alexander Bukreyev, a virologist from the University of Texas MedicalBranch and one of the paper’s authors. “This is one of the few vaccines that works.